AAV2-R100 Serotype
AAV2 variant engineered for enhanced CNS penetration through rational capsid modification with improved neuronal transduction.
| Tropism | CNS (neurons), reduced glial transduction |
|---|
Characteristics
Single amino acid substitutions improve neuronal specificity. Reduced glial tropism compared to wild-type AAV2. Enhanced CNS penetration following systemic administration.
Applications
Neurological disorders requiring neuron-specific gene delivery. Preclinical CNS gene therapy research.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Qiao et al. (2017). Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Mol Ther — Qiao 2017 AAV2 Variants
